Advanced Micro Devices (AMD - Get Report) was upgraded to buy from hold at Canaccord Genuity. $6 price target. The company can return to profitability, given demand for FinFET products and virtual reality, Canaccord said.
Amsurg (AMSG) was upgraded to buy from underperform at Bank of America/Merrill Lynch. $104 price target. EVHC deal increases scale and should materially add to earnings, analysts said.
Cavium (CAVM) was downgraded to hold from buy at Canaccord Genuity. $48 price target. QLogic purchase raises near-term strategic and valuation concerns, Canaccord said.
Cavium was downgraded to sector weight at Pacific Crest. QLogic deal adds execution risk to the thesis, Pac Crest said.
Cavium was downgraded to perform from outperform at Oppenheimer. QLogic deal appears to make little strategic sense, Oppenheimer said.
Yahoo! (YHOO) was upgraded to buy from neutral at Citigroup. The valuation is attractive, based on a $43 price target, Citi said.